The Discovery
Margaret’s discovery of the unmarked facility occurred on a rainy Thursday afternoon in October. She had been driving to inspect a legitimate storage facility when her GPS malfunctioned, directing her down a series of increasingly remote industrial roads. When she finally stopped to recalibrate her navigation system, she found herself in front of a large, modern warehouse complex that looked exactly like the other MediCore facilities she visited regularly.
The building was substantial—approximately 50,000 square feet of climate-controlled storage space surrounded by high security fencing and surveillance cameras. The architecture was consistent with pharmaceutical industry standards for sensitive material storage, including specialized ventilation systems, temperature monitoring equipment, and the kind of robust security measures required for facilities handling controlled substances.
What made the facility unusual wasn’t its appearance but its absence from all official company documentation. Margaret had access to comprehensive databases listing every MediCore facility, storage location, and research site. She knew the locations, purposes, and regulatory status of dozens of facilities across the Pacific Northwest. This building simply didn’t exist in any official records.
Her first instinct was to assume she had stumbled onto a facility belonging to a different pharmaceutical company. The industry was highly competitive, and companies often built their facilities in similar locations and used comparable architectural standards. But as she looked more closely, she could see the distinctive MediCore logo discreetly placed near the main entrance, along with security equipment and access panels that were identical to those used at other company facilities.
